Objective-Disruption of scavenger receptor class B type I (SR-BI) in mice impairs high-density lipoprotein (HDL)-cholesterol (HDL-C) delivery to the liver and induces susceptibility to atherosclerosis. In this study, it was investigated whether introduction of cholesteryl ester transfer protein (CETP) can normalize HDL-C transport to the liver and reduce atherosclerosis in SR-BI knockout (KO) mice. Methods and Results-Expression of human CETP in SR-BI KO mice resulted in decreased plasma HDL-C levels, both on chow diet (1.8-fold, PϽ0.001) and on challenge with Western-type diet (1.6-fold, PϽ0.01). Furthermore, the presence of CETP partially normalized the abnormally large HDL particles observed in SR-BI KO mice. Unexpectedly, expression of CETP in SR-BI KO mice did not reduce atherosclerotic lesion development, probably because of consequences of SR-BI deficiency, including the persistence of higher VLDL-cholesterol (VLDL-C) levels, unchanged elevated free cholesterol/total cholesterol ratio, and the increased oxidative status of the animals. In addition, CETP expression did not normalize other characteristics of SR-BI deficiency, including female infertility, reticulocytosis, thrombocytopenia, and impaired platelet aggregation. everal epidemiological studies have shown that highdensity lipoprotein (HDL) cholesterol is inversely related to the risk of atherosclerotic lesion development. 1 High levels of HDL in plasma protect against atherosclerosis by facilitating reverse cholesterol transport, a process by which cholesterol is transported from peripheral cells to the liver via HDL. 2 An important player in HDL metabolism is scavenger receptor class B type I (SR-BI), a cell surface receptor that is highly expressed in liver and steroidogenic tissues and mediates the selective uptake of cholesteryl esters (CE) from HDL. 3 Disruption of SR-BI in mice (SR-BI KO ) causes the accumulation of cholesterol in HDL, resulting in larger HDL particles. 4 Despite the elevated plasma HDL-cholesterol (HDL-C) levels, these mice are more susceptible to atherosclerotic lesion development. 5 In the Framingham Heart Study, Ϸ45% of all clinical events occurred in subjects with normal or elevated HDL-C levels, 6 suggesting that not only the HDL-C levels per se but also other HDL-associated factors are important. The proatherogenic effects of SR-BI deficiency have primarily been attributed to disruption of the flux of cholesterol through the reverse cholesterol transport pathway. However, besides the well-known role of SR-BI in HDL metabolism, SR-BI is also important for facilitating chylomicron 7 and very-low-density lipoprotein (VLDL, 8 ) metabolism in wild-type (WT) mice. Furthermore, SR-BI is responsible for clearance of remnants from the circulation in apolipoprotein (apo) E-deficient mice. 9 Thus, the antiatherogenic properties of SR-BI could also be attributed to its role in promoting the clearance of atherogenic apoB-containing lipoproteins. In addition, SR-BI deficiency is associated with a significant increase in oxidative stress in vivo, potentially contributing to the proatherogenic effect of SR-BI deficiency. 10
S
everal epidemiological studies have shown that highdensity lipoprotein (HDL) cholesterol is inversely related to the risk of atherosclerotic lesion development. 1 High levels of HDL in plasma protect against atherosclerosis by facilitating reverse cholesterol transport, a process by which cholesterol is transported from peripheral cells to the liver via HDL. 2 An important player in HDL metabolism is scavenger receptor class B type I (SR-BI), a cell surface receptor that is highly expressed in liver and steroidogenic tissues and mediates the selective uptake of cholesteryl esters (CE) from HDL. 3 Disruption of SR-BI in mice (SR-BI KO ) causes the accumulation of cholesterol in HDL, resulting in larger HDL particles. 4 Despite the elevated plasma HDL-cholesterol (HDL-C) levels, these mice are more susceptible to atherosclerotic lesion development. 5 In the Framingham Heart Study, Ϸ45% of all clinical events occurred in subjects with normal or elevated HDL-C levels, 6 suggesting that not only the HDL-C levels per se but also other HDL-associated factors are important. The proatherogenic effects of SR-BI deficiency have primarily been attributed to disruption of the flux of cholesterol through the reverse cholesterol transport pathway. However, besides the well-known role of SR-BI in HDL metabolism, SR-BI is also important for facilitating chylomicron 7 and very-low-density lipoprotein (VLDL, 8 ) metabolism in wild-type (WT) mice. Furthermore, SR-BI is responsible for clearance of remnants from the circulation in apolipoprotein (apo) E-deficient mice. 9 Thus, the antiatherogenic properties of SR-BI could also be attributed to its role in promoting the clearance of atherogenic apoB-containing lipoproteins. In addition, SR-BI deficiency is associated with a significant increase in oxidative stress in vivo, potentially contributing to the proatherogenic effect of SR-BI deficiency. 10 Although the function of SR-BI in HDL metabolism and atherosclerosis has been well established in genetically engineered mice, the role of CLA-1 (CD36 and LIMPII analogous-1), the human homologue of SR-BI, in human metabolism is still largely unknown. The role of SR-BI in human HDL metabolism might be influenced by the presence of CE transfer protein (CETP), which transfers CE from HDL to apoB-containing lipoproteins that are subsequently rapidly taken up by the liver. 11 CETP is a hydrophobic plasma glycoprotein with a widespread tissue distribution. The highest levels of CETP mRNA are found in liver, spleen, and adipose tissue, 12 whereas CETP is also locally expressed in the human arterial wall. 13 Mice naturally lack CETP. 14 Transgenic (Tg) mice expressing human CETP have decreased levels of HDL and an increased susceptibility to atherosclerosis, indicating that CETP is a proatherogenic factor. 15 However, in absence of SR-BI, CETP might offer an alternate route for reverse cholesterol transport, thereby possibly preventing atherosclerosis. In line with this, Harder et al 16 indeed showed HDL-C lowering and decreased atherosclerotic lesion development in SR-BI KO mice on expression of CETP under control of the human apoAI promoter. However, in these mice, CETP was solely expressed in the liver and was not regulated in response to high-fat/high-cholesterol diet feeding.
The aim of the current study was to study the influence of CETP plasma activity on HDL cholesterol metabolism and atherosclerotic lesion development in SR-BI KO mice expressing human CETP under control of its own promoter (SR-BI KO /CETP Tg , 17). Interestingly, despite the decreased plasma HDL-C levels and normalized HDL particle size in SR-BI KO /CETP Tg animals, CETP activity did not reduce lesion development, nor did it normalize other pathologies associated with SR-BI deficiency.
Methods
For detailed methodology, please see the data supplement, available online at http://atvb.ahajournals.org.
In short, SR-BI KO mice expressing CETP (SR-BI KO /CETP Tg ) were generated by crossbreeding heterozygous SR-BI KO mice with CETP Tg mice overexpressing human CETP under the control of its own promoter and other major regulatory elements. 17 To induce atherosclerosis, mice were challenged with a Western-type diet (WTD) for 20 weeks, and atherosclerotic lesion size, serum lipids, the activity of CETP and lecithin:cholesterol acyltransferase (LCAT), blood cell counts, and oxidation markers (isoprostanes and carbonyls) were determined. Furthermore, serum decay and liver uptake of [ 3 H]cholesteryl ether-labeled HDL and ex vivo aggregation of platelets were analyzed. (Table) . This decrease in serum cholesterol can be attributed to lower HDL-C concentrations and a smaller HDL particle size, as assessed by fast protein liquid chromatography (Figure 1 ). Although HDL-C was normalized on expression of CETP in SR-BI KO (Table) . The TC levels in plasma increased 2-fold on diet feeding in SR-BI KO mice in both male and female animals. In SR-BI KO /CETP Tg animals, a similar 2-fold increase of plasma TC was seen in males, whereas the levels increased 3-fold in females. Importantly, also under these dietary conditions, CETP expression in SR-BI KO mice resulted in reduced plasma TC and FC levels, although not to WT levels (Table) LCAT activity, the major enzyme for the esterification of FC. In males, however, no difference on endogenous or exogenous activity was observed (Supplemental Figure I) . Similar to the effects observed on chow diet, plasma cholesterol levels were lower in SR-BI KO 
Results

The Effects of CETP Expression in
/CETP
Tg mice on WTD because of a decrease in HDL-C levels (males: 1.9-fold, PϽ0.001 and females: 1.6-fold, PϽ0.001; Table, Figure 1 ). VLDL-C levels, however, were similarly high in SR-BI KO Figure 1B) . After 20 weeks of WTD feeding, the mice were euthanized, and the lesion size in the aortic root was quantified. In all groups, lesions were early foam cell-rich lesions. Interestingly, in both the male and female groups, no difference in lesion size was observed between SR-BI KO Figure 3) . Thus, remarkably, restoration of the delivery route of HDL-C through the expression of CETP in SR-BI KO mice was not associated with a reduced atherosclerosis susceptibility of these animals.
To gain further insight as to why atherosclerotic lesion development in SR-BI KO /CETP Tg mice was not reduced despite restoration of the reverse cholesterol transport pathway, the effect of CETP expression in SR-BI KO mice on the oxidative status of these mice was investigated. To this end, serum, urine, liver, spleen, and the aortic arch were isolated from SR-BI KO and SR-BI KO 
Tg mice fed WTD for 20 weeks. As previously shown, 10 SR-BI KO animals displayed a 2.6-fold increase of the isoprostane 8,12-iso-isoprostane F2alpha-VI (iPF 2␣ ) in plasma, a 1.5-fold increase in urine, and an enhanced accumulation in liver, spleen, and aorta compared with animals with functional SR-BI fed WTD. Interestingly, CETP expression in SR-BI KO mice did not result in a normalization of the levels of 8,12-isoiPF 2␣ -VI in serum, urine, liver, and the aortic arch in either male or female mice (Figure 4 ). In fact, in CETP-expressing SR-BI KO mice, a tendency to increased levels of 8,12-iso-iPF 2␣ -VI was observed in urine and the different organs analyzed; this increase, however, reached statistical significance only for the spleen. In addition, the levels of carbonyls in serum, spleen, and aorta of SR-BI KO mice 13 increased slightly with expression of CETP (Supplemental Figure II) .
The Effect of CETP Activity on Female Infertility, Reticulocytosis, and Platelet Abnormalities of SR-BI KO Mice
SR-BI deficiency is associated not only with the accumulation of enlarged HDL particles and an increased susceptibility to atherosclerosis but also with female infertility 18 and a dramatically reduced lifespan of erythrocytes, leading to enhanced erythropoietic activity and the accumulation of reticulocytes. 19, 20 Interestingly, CETP expression could also not overcome the infertility of SR-BI KO female mice, as no litters were obtained over a period of 6 months. As previously described for SR-BI KO mice, 18 female infertility of SR-BI KO /CETP Tg mice was restored by feeding breeding pairs a diet containing 0.25% probucol. Regarding reticulocytosis, the presence of CETP decreased the reticulocyte counts from 241Ϯ34%% (nϭ6) to 143Ϯ24%% (nϭ8) (PϽ0.05) in male SR-BI KO animals. However, the levels remained substantially higher than those of WT controls (33Ϯ3%% [nϭ6] ). In female animals that showed a less dramatic accumulation of reticulocytes in the circulation, no statistically significant reduction in the reticulocyte counts was observed (82Ϯ7%% In addition to its effects on female fertility and erythrocyte metabolism, SR-BI deficiency is also associated with platelet abnormalities, including abnormally low platelet counts and impaired platelet aggregation. 21 The decreased platelet counts in SR-BI KO mice (males, 257Ϯ4ϫ10 Figure 5A ). Furthermore, CETP expression did not normalize platelet aggregation induced by PAR-4 peptide that activates the thrombin receptor ( Figure 5B ).
Discussion
SR-BI is the sole receptor responsible for the delivery of HDL-CE to the liver in mice. 22 In humans, however, CETP facilitates an alternate route for the delivery of HDL-CE to the liver after transfer to VLDL and LDL and subsequent uptake by the LDL receptor or LDL receptor-related protein. 23 In this study, we show that expression of CETP in SR-BI KO mice indeed increased the delivery of HDL-CEt to the liver, probably after transfer to VLDL and LDL and partially normalized HDL-C levels and HDL particle size. Strikingly, in spite of these plasma lipid changes, the enhanced susceptibility of these animals to diet-induced atherosclerosis was not influenced. In addition, other pathologies that are associated with SR-BI disruption, including female infertility, reticulocytosis, thrombocytopenia, and impaired platelet aggregation, were not normalized by CETP. These findings indicate that the pathophysiology of SR-BI deficiency is not a direct consequence of the accumulation of the abnormally large HDL particles.
Previously, Harder et al 16 did find a similar partial normalization of HDL-C in SR-BI KO mice on expression of CETP under control of the human apoAI promoter. However, in contrast to our study, a decrease in atherosclerotic lesion development was observed. In these mice, CETP was exclusively expressed in the liver. In our study, Tg mice were used expressing human CETP under control of its own promoter and other major regulatory elements. 17 These mice show CETP expression in liver, spleen, small intestine, kidney, adipose tissue, and macrophages. 17 In addition, as also shown in this study, CETP expression is upregulated in response to high fat/high cholesterol diet feeding. 17 The difference in expression patterns and regulation of CETP might thus have resulted in the differential outcome of the 2 studies.
SR-BI deficiency in mice results in a delayed clearance of HDL-CE from plasma and a diminished uptake by the liver. 22 Under normal conditions, FC in HDL is rapidly esterified by HDL-associated LCAT. 24 The abnormal large HDL particles that accumulate in SR-BI KO mice, however, are poor substrates for LCAT, 25 leading to an impaired LCAT activity 26 and a marked increase in the FC/TC ratio in these animals. Expression of CETP in SR-BI KO mice resulted in a partial normalization of HDL particle size by inducing the transfer of CE from HDL to VLDL/LDL. However, the FC/TC ratio remained elevated in the SR-BI KO 
/CETP
Tg animals, and the LCAT activity was significantly increased only in females but not in males, indicating that the increased FC/TC ratio of SR-BI KO mice is not solely the consequence of an impaired LCAT activity. SR-BI is not only essential for the selective delivery of HDL-CE to the liver, 3, 22 but has also been implicated in the bidirectional flux of FC between cells and HDL. 27 The increased FC/TC ratio in SR-BI KO mice might thus also be a direct consequence of the role of SR-BI in the flux of FC. Excess FC in cells is highly cytotoxic 28 and FC loading is associated with macrophage death during the progression of atherosclerosis. 29 The elevated FC/TC ratio might thus be causal for several of the pathologies observed in SR-BI KO mice and not a direct effect of the abnormally large HDL particles. Concurrently, the female infertility was not restored in SR-BI KO / CETP Tg animals, despite normalization of the HDL particle size. Another remarkable phenotypic change in SR-BI KO mice is an enhanced erythropoietic activity, associated with unusual erythrocyte morphology and abnormally high reticulocyte counts in blood. This is probably caused by impaired maturation and enhanced turnover of erythrocytes due to the abnormally high FC levels in the blood circulation, leading to accumulation of excess FC in the membranes of erythrocytes. 19, 20 In addition, SR-BI deficiency in mice leads to splenomegaly, probably because of hematopoietic compensation. 19 7 ; and (4) SR-BI protects against oxidative stress. 10 The high atherosclerosis susceptibility of SR-BI KO 
Tg mice might thus simply be a direct consequence of the absence of SR-BI in cells of the arterial wall, including macrophages and endothelial cells. Previously, we have shown that macrophages from CETP TG mice do not show any alteration in cholesterol efflux to lipid-free apoAI or to HDL compared with those from WT mice. 33 Therefore, it is unlikely that CETP expression will have affected the cholesterol efflux capacity of SR-BI deficient macrophages. Alternatively, VLDL-C levels and the oxidative status remained elevated and might thus have contributed to the atherosclerosis susceptibility of the SR-BI KO /CETP Tg animals. Interestingly, the oxidative status of SR-BI KO /CETP Tg mice remained increased despite decreased HDL particle size and partial normalization of HDL lipid composition by CETP. Thus, although small, dense HDL particles have a higher antioxidative activity than large HDL, 34 the elevated oxidative status of SR-BI KO mice appears not related to the presence of enlarged HDL particles in these animals. It may be possible that other mechanisms that are associated with SR-BI deficiency, such as impaired removal of oxidized lipids from the circulation 10 and reduced bioavailability of dietary antioxidants such as beta carotene 35 and ␣-tocopherol, 36 are causative for the increased oxidative stress observed in SR-BI KO /CETP Tg mice. In conclusion, although CETP activity can restore the transport of HDL-CE to the liver in SR-BI KO mice, it cannot normalize many other processes associated with disruption of SR-BI in mice, nor the susceptibility to atherosclerosis. Importantly, these results indicate that the enhanced atherosclerosis in SR-BI KO mice is not directly correlated with the accumulation of large HDL in these animals but can merely be attributed to other consequences of SR-BI deficiency, including increased oxidative stress, increased plasma FC/TC ratio, and accumulation of VLDL-C. Furthermore, based on these findings, functional SR-BI mutations in humans who do naturally express CETP are expected to be associated with pathologies similar to those observed in SR-BI KO mice.
Sources of Funding
